Takagi Haruhi 高木陽

Researcher Number	40868907
Affiliation (based on the past Project Information) *help	2021 – 2022: 順天堂大学, 大学院医学研究科, 非常勤助教 2020: 順天堂大学, 医学(系)研究科(研究院), 助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator 免疫チェックポイント分子 / 非扁平小細胞肺がん / 非扁平非小細胞肺がん / 腫瘍免疫応答誘導 / テロメラーゼ活性 / 免疫チェックポイント分子 / ペメトレキセド

Research Projects
(1 results)
Research Products
(3 results)

Phenotyping of white blood cells contributing to tumor immunity activated by pemetrexedPrincipal Investigator
- Principal Investigator
  
  Takagi Haruhi
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Juntendo University

All 2022 2021

All Journal Article

[Journal Article] The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force2022
- Author(s)
  Wang Qingbo S.、et al.
- Journal Title
  
  Nature Communications
  
  Volume: 13 Issue: 1 Pages: 4830-4830
- DOI
  10.1038/s41467-022-32276-2
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08606, KAKENHI-PROJECT-22K08283, KAKENHI-PROJECT-18H05282, KAKENHI-PROJECT-22H00476, KAKENHI-PROJECT-20H03684, KAKENHI-PROJECT-19K08650, KAKENHI-PROJECT-20K16453, KAKENHI-PROJECT-20K17460
[Journal Article] DOCK2 is involved in the host genetics and biology of severe COVID-192022
- Author(s)
  Namkoong Ho、et al.
- Journal Title
  
  Nature
  
  Volume: 609 Issue: 7928 Pages: 754-760
- DOI
  10.1038/s41586-022-05163-5
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08606, KAKENHI-PROJECT-22K08283, KAKENHI-PROJECT-18H05282, KAKENHI-PROJECT-22H00476, KAKENHI-PROJECT-20H03684, KAKENHI-PROJECT-19K08650, KAKENHI-PROJECT-20K16453
[Journal Article] High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational study2021
- Author(s)
  Sumiyoshi Issei、Okabe Takahiro、Togo Shinsaku、Takagi Haruhi、Motomura Hiroaki、Ochi Yusuke、Shimada Naoko、Haraguchi Mizuki、Shibayama Rina、Fujimoto Yuichi、Watanabe Junko、Iwai Moe、Kadoya Kotaro、Iwakami Shin-ichiro、Takahashi Kazuhisa
- Journal Title
  
  Journal of Translational Medicine
  
  Volume: 19 Issue: 1 Pages: 92-92
- DOI
  10.1186/s12967-021-02761-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K16453, KAKENHI-PROJECT-21K16122

Takagi Haruhi 高木 陽

Research Projects

Research Products

Phenotyping of white blood cells contributing to tumor immunity activated by pemetrexedPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] DOCK2 is involved in the host genetics and biology of severe COVID-192022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational study2021

Author(s)

Journal Title

DOI

Data Source

Takagi Haruhi 高木陽